Tao Yu

Prof. Dr. Tao Yu


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 May 2024 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
YLYanqing Lin
Yanqing Lin
Ruosen XieRuosen Xie
Ruosen Xie
TYTao Yu
Tao Yu
This review paper examines the evolution of photodynamic therapy (PDT) as a novel, minimally invasive strategy for treating atherosclerosis, a leading global health concern. Atherosclerosis is characterized by the accumulation of lipids and inflammation within arterial walls, leading to significant morbidity and mortality through cardiovascular diseases such as myocardial infarction and stroke. Traditional therapeutic approaches have primarily focused on modulating risk factors such as hypertension and hyperlipidemia, with emerging evidence highlighting the pivotal role of inflammation. PDT, leveraging a photosensitizer, specific-wavelength light, and oxygen, offers targeted treatment by inducing cell death in diseased tissues while sparing healthy ones. This specificity, combined with advancements in nanoparticle technology for improved delivery, positions PDT as a promising alternative to traditional interventions. The review explores the mechanistic basis of PDT, its efficacy in preclinical studies, and the potential for enhancing plaque stability and reducing macrophage density within plaques. It also addresses the need for further research to optimize treatment parameters, mitigate adverse effects, and validate long-term outcomes. By detailing past developments, current progress, and future directions, this paper aims to highlight PDT’s potential in revolutionizing atherosclerosis treatment, bridging the gap from experimental research to clinical application.

13 September 2024 in International Journal of Biological Macromolecules
Verified
Journal Article
Closed access
YLYingxue Li
Yingxue Li
TZTingrui Zhang
Tingrui Zhang
GBGang Bai
Gang Bai
MCMengchun Chen
Mengchun Chen
XLXiaodong Lei
Xiaodong Lei
TYTao Yu
Tao Yu

16 October 2026 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
LYLi Ye
Li Ye
ZFZhichao Fan
Zhichao Fan
XZXin Zhang
Xin Zhang
YCYanrong Chen
Yanrong Chen
JZJie Zhang
Jie Zhang
HYHua Yu
Hua Yu
Liver disease is a serious global health challenge, with high morbidity and mortality that put significant socioeconomic stress on society. Despite therapeutic advances, current regimens have been limited by rapid drug resistance and insufficient targeting accuracy, and there is an urgent need for new methods. Plant-derived exosome-like nanoparticles (PELNs) are a promising natural nanotherapeutic platform due to their low immunogenicity, high biocompatibility, and prolonged stability in biological fluids. We review the biological sources, basic properties, and key preparative techniques for PELNs and characterize their mechanisms of action and therapeutic use in common liver diseases. We analyze their multiple-target hepatoprotective mechanisms including liver-specific targeting pathways and reducing critical inflammatory and antioxidant cascades. We summarize the therapeutic performance of different PELNs in major hepatic models including hepatocellular carcinoma, hepatic fibrosis, alcohol-related liver disease, and acute liver failure, highlighting key plant sources, primary biological effects, and precise molecular pathways. Moreover, one of the major methodological contributions of this work is the proposal of a new recommended extraction framework based on differential and density gradient centrifugation, optimized specifically for different plant tissue types (leaves, roots/stems, and fruits) to minimize technical heterogeneity. Finally, we discuss the major challenges that impede clinical translation of these nanovesicles, including incompletely elucidated mechanisms, imperfect manufacturing practices, and inadequate safety evaluation mechanisms, pointing to important, useful directions for future applications in hepatology.